AAAAAA

   
Results: 1-23 |
Results: 23

Authors: HUNZELMANN N KOCHANEK KS HAGER C KRIEG T
Citation: N. Hunzelmann et al., MANAGEMENT OF LOCALIZED SCLERODERMA, Seminars in cutaneous medicine and surgery, 17(1), 1998, pp. 34-40

Authors: KRUPPA A SCHARFFETTERKOCHANEK K KRIEG T HUNZELMANN N
Citation: A. Kruppa et al., IMMEDIATE REACTION TO ROXITHROMYCIN AND PRICK TEST CROSS-SENSITIZATION TO ERYTHROMYCIN AND CLARITHROMYCIN, Dermatology, 196(3), 1998, pp. 335-336

Authors: HAGER CM SOBHI HA HUNZELMANN N WICKENHAUSER C SCHARENBERG R KRIEG T SCHARFFETTERKOCHANEK K
Citation: Cm. Hager et al., BATH-PUVA THERAPY IN 3 PATIENTS WITH SCLEREDEMA ADULTORUM, Journal of the American Academy of Dermatology, 38(2), 1998, pp. 240-242

Authors: SEGURA JA ASSENMACHER M IRSCH J HUNZELMANN N RADBRUCH A
Citation: Ja. Segura et al., SYSTEMIC T-CELL UNRESPONSIVENESS DURING RUSH BEE-VENOM IMMUNOTHERAPY, Allergy, 53(3), 1998, pp. 233-240

Authors: HUNZELMANN N GOLD H SCHARFFETTERKOCHANEK K
Citation: N. Hunzelmann et al., CONCOMITANT SENSITIZATION TO HIGH AND LOW-MOLECULAR-WEIGHT HEPARINS, HEPARINOID AND PENTOSANPOLYSULFATE, Contact dermatitis, 39(2), 1998, pp. 88-89

Authors: TRAIDL C JUGERT F MERK H HUNZELMANN N
Citation: C. Traidl et al., CONTACT HYPERSENSITIVITY REACTION TO OXAZOLONE IS INDEPENDENT WHEREASCONTACT HYPERSENSITIVITY REACTION TO DNCB IS DEPENDENT ON IL-4, Journal of investigative dermatology, 110(4), 1998, pp. 648-648

Authors: HAGER CM CASPER C HUNZELMANN N SOHBI HA HUERKAMP CJ KRIEG T SCHARFFETTERKOCHANEK K
Citation: Cm. Hager et al., EVALUATION OF BATH-PUVA THERAPY IN PATIENTS WITH MORPHEA BY ANALYZINGHISTOLOGIC, ULTRASONIC AND CLINICAL-PARAMETERS, Journal of investigative dermatology, 110(4), 1998, pp. 701-701

Authors: HUNZELMANN N HAFNER M ANDERS S KRIEG T NISCHT R
Citation: N. Hunzelmann et al., BM-40 (OSTEONECTIN, SPARC) IS EXPRESSED BOTH IN THE EPIDERMAL AND IN THE DERMAL COMPARTMENT OF ADULT HUMAN SKIN, Journal of investigative dermatology, 110(2), 1998, pp. 122-126

Authors: SMOLA H KRUPPA A HUNZELMANN N KRIEG T SCHARFFETTERKOCHANEK K
Citation: H. Smola et al., IDENTIFICATION OF DIMENHYDRINATE AS THE CAUSATIVE AGENT IN FIXED DRUGERUPTION USING PATCH-TESTING IN PREVIOUSLY AFFECTED SKIN, British journal of dermatology, 138(5), 1998, pp. 920-921

Authors: HUNZELMANN N UEBERHAM U ECKES B HERRMANN K KRIEG T
Citation: N. Hunzelmann et al., TRANSFORMING GROWTH-FACTOR-BETA REVERSES DEFICIENT EXPRESSION OF TYPE-(I) COLLAGEN IN CULTURED FIBROBLASTS OF A PATIENT WITH METAGERIA, Biochimica et biophysica acta. Molecular basis of disease, 1360(1), 1997, pp. 64-70

Authors: HUNZELMANN N ANDERS S FIERLBECK G HEIN R HERRMANN K ALBRECHT M BELL S MUCHE R WEHNERCAROLI J GAUS W KRIEG T
Citation: N. Hunzelmann et al., DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF INTRALESIONAL INTERFERON-GAMMA FOR THE TREATMENT OF LOCALIZED SCLERODERMA, Journal of the American Academy of Dermatology, 36(3), 1997, pp. 433-435

Authors: HUNZELMANN N RISTELI J BISTELI L SACHER C BLACK C KRIEG T
Citation: N. Hunzelmann et al., CIRCULATING CONCENTRATIONS OF TYPE-I COLLAGEN SPECIFIC DEGRADATION PRODUCTS - A NEW SERUM MARKER REFLECTING SKIN FIBROSIS IN SCLERODERMA PATIENTS, Journal of investigative dermatology, 109(3), 1997, pp. 421-421

Authors: TRAIDL C JUGERT F KRIEG T MERK H HUNZELMANN N
Citation: C. Traidl et al., LOSS OF INTERLEUKIN-4 GENE-EXPRESSION IN BALB C MICE INHIBITS ALLERGIC AND IRRITANT CONTACT-DERMATITIS/, Journal of investigative dermatology, 109(3), 1997, pp. 453-453

Authors: HUNZELMANN N ANDERS S FIERLBECK G HEIN R HERRMANN K ALBRECHT M BELL S THUR J MUCHE R ADELMANNGRILL B WEHNERCAROLI J GAUS W KRIEG T
Citation: N. Hunzelmann et al., SYSTEMIC SCLERODERMA - MULTICENTER TRIAL OF 1-YEAR OF TREATMENT WITH RECOMBINANT INTERFERON-GAMMA, Archives of dermatology, 133(5), 1997, pp. 609-613

Authors: RONNAU AC SACHS B VONSCHMIEDEBERG S HUNZELMANN N RUZICKA T GLEICHMANN E SCHUPPE HC
Citation: Ac. Ronnau et al., CUTANEOUS ADVERSE REACTION TO CIPROFLOXACIN - DEMONSTRATION OF SPECIFIC LYMPHOCYTE-PROLIFERATION AND CROSS-REACTIVITY TO OFLOXACIN IN-VITRO, Acta dermato-venereologica, 77(4), 1997, pp. 285-288

Authors: THUR J NISCHT R KRIEG T HUNZELMANN N
Citation: J. Thur et al., QUANTITATIVE-ANALYSIS OF ALPHA-1(I) PROCOLLAGEN TRANSCRIPTS IN-VIVO BY COMPETITIVE POLYMERASE CHAIN-REACTION, Matrix biology, 15(1), 1996, pp. 49-52

Authors: HUNZELMANN N HAFNER M ANDERS S KRIEG T NISCHT R
Citation: N. Hunzelmann et al., BM-40 (OSTEONECTIN, SPARC) IS EXPRESSED IN THE EPIDERMIS OF ADULT HUMAN SKIN, Journal of investigative dermatology, 107(3), 1996, pp. 157-157

Authors: HUNZELMANN N ANDERS S SOLLBERG S SCHONHERR E KRIEG T
Citation: N. Hunzelmann et al., COORDINATE INDUCTION OF COLLAGEN TYPE-I AND BIGLYCAN EXPRESSION IN KELOIDS, British journal of dermatology, 135(3), 1996, pp. 394-399

Authors: JARISCH A KRIEG T HUNZELMANN N
Citation: A. Jarisch et al., REGULATION OF COLLAGEN EXPRESSION BY INTERLEUKIN-1-BETA IS DEPENDENT ON DONOR AGE, Acta dermato-venereologica, 76(4), 1996, pp. 287-290

Authors: HUNZELMANN N ANDERS S FIERLBECK G HEIN R HERMANN K ALBRECHT M BELLBRANDT S MUCHE R WEHNERCAROLL J GAUS W KRIEG T
Citation: N. Hunzelmann et al., DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF IFN-GAMMA FOR THE TREATMENT OF LOCALIZED SCLERODERMA, Journal of investigative dermatology, 105(3), 1995, pp. 483-483

Authors: HUNZELMANN N SCHONHERR E BONNEKOH B HARTMANN C KRESSE H KRIEG T
Citation: N. Hunzelmann et al., ALTERED IMMUNOHISTOCHEMICAL EXPRESSION OF SMALL PROTEOGLYCANS IN THE TUMOR-TISSUE AND STROMA OF BASAL-CELL CARCINOMA, Journal of investigative dermatology, 104(4), 1995, pp. 509-513

Authors: HUNZELMANN N
Citation: N. Hunzelmann, APPLICATION OF NEW METHODS FOR THE DIAGNO SIS OF IMMUNOLOGICALLY MEDIATED BULLOUS DERMATOSES, Allergologie, 17(10), 1994, pp. 481-485

Authors: HUNZELMANN N ANDERS S KRESSE H KRIEG T
Citation: N. Hunzelmann et al., COORDINATE INDUCTION OF COLLAGEN TYPE-I AND BIGLYCAN BUT NOT DECORIN EXPRESSION IN KELOIDS, Journal of investigative dermatology, 103(3), 1994, pp. 445-445
Risultati: 1-23 |